Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Southern medical journal (Birmingham, Ala.) Ala.), 1997-03, Vol.90 (3), p.364-365
Hauptverfasser:	Fleming, D R, Mangino, P B
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Alkylating - administration & dosage Antineoplastic Agents, Alkylating - adverse effects Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Etoposide - administration & dosage Etoposide - adverse effects Hemofiltration Humans Immunoglobulin kappa-Chains Male Middle Aged Multiple Myeloma - drug therapy Parkinson Disease, Secondary - chemically induced Renal Insufficiency - complications Renal Insufficiency - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!